Genomic disorders: Molecular mechanisms for rearrangements and conveyed phenotypes

PLoS Genetics

Volumn 1, Issue 6, 2005, Pages 0627-0633

  Lupski, James R ^a   Stankiewicz, Pawel ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BASE PAIRING; CHEMISTRY; GENE DUPLICATION; GENE REARRANGEMENT; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETICS; GENOME; HUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE PAIRING; DNA; GENE DUPLICATION; GENE REARRANGEMENT; GENETIC DISEASES, INBORN; GENOME, HUMAN; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINATION, GENETIC;

EID: 34547664096     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0010049     Document Type: Review

References (76)

1. Lupski JR (1998) Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14: 417-422.
2. Stankiewicz P, Lupski JR (2002) Genome architecture, rearrangements and genomic disorders. Trends Genet 18: 74-82.
3. Shaw CJ, Lupski JR (2004) Implications of human genome architecture for rearrangement-based disorders: The genomic basis of disease. Hum Mol Genet 13(Spec No 1): R57-R64.
4. Lupski JR (2003) 2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture. Am J Hum Genet 72: 246-252.
5. Lupski JR, Garcia A (2001) Charcot-Marie-Tooth peripheral neuropathies and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, et al., editors. The metabolic and molecular bases of inherited diseases, 8th ed. New York: McGraw-Hill. pp. 5759-5788.
6. Lupski JR, Chance PF (2005) Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: The CMT1A duplication and HNPP deletion. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Science, pp. 1659-1680.
7. Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 9: 1533-1537.
8. Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, et al. (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 10: 396-401.
9. Chen KS, Potocki L, Lupski JR (1996) The Smith-Magenis syndrome [del(17)p11.2]: Clinical review and molecular advances. In: McCabe ERB, editor. Mental retardation and developmental disabilities research reviews. pp. 122-129.
10. Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, et al. (1996) Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet 62: 247-254.
11. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH (2003) Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 33: 466-468.
12. Bi W, Saifi GM, Shaw CJ, Walz K, Fonseca P, et al. (2004) Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Hum Genet 115: 515-524.
13. Girirajan S, Elsas LJ 2nd, Devriendt K, Elsea SH (2005) RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet 42: 820-828.
14. Walz K, Caratini-Rivera S, Bi W, Fonseca P, Mansouri DL, et al. (2003) Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: Phenotypic consequences of gene dosage imbalance. Mol Cell Biol 23: 3646-3655.
15. Walz K, Spencer C, Kaasik K, Lee CC, Lupski JR, et al. (2004) Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). Hum Mol Genet 13: 367-378.
16. Yan J, Keener VW, Bi W, Walz K, Bradley A, et al. (2004) Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome. Hum Mol Genet 13: 2613-2624.
17. Bi W, Ohyama T, Nakamura H, Yan J, Visvanathan J, et al. (2005) Inactivation of Rail in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum Mol Genet 14: 983-995.
18. Potocki L, Chen KS, Park SS, Osterholm DE, Withers MA, et al. (2000) Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 24: 84-87.
19. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219-232.
20. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, et al. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151.
21. Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR (1992) Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 2: 292-300.
22. Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, et al. (1994) Two autosomal dominant neuropathies result from reciprocal DNA duplication/ deletion of a region on chromosome 17. Hum Mol Genet 3: 223-228.
23. Smith AC, McGavran L, Robinson J, Waldstein G, Macfarlane J, et al. (1986) Interstitial deletion of (17)(p11.2p11-2) in nine patients. Am J Med Genet 24: 393-414.
24. Stratton RF, Dobyns WB, Greenberg F, DeSana JB, Moore C, et al. (1986) Interstitial deletion of (17)(p11.2p11-2): Report of six additional patients with a new chromosome deletion syndrome. Am J Med Genet 24: 421-432.
25. Greenberg F, Guzzetta V, Montes de Oca-Luna R, Magenis RE, Smith AC, et al. (1991) Molecular analysis of the Smith-Magenis syndrome: A possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet 49: 1207-1218.
26. Juyal RC, Figuera LE, Hauge X, Elsea SH, Lupski JR, et al. (1996) Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. Am J Hum Genet 58: 998-1007.
27. Chen KS, Manian P, Koeuth T, Potocki L, Zhao Q, et al. (1997) Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat Genet 17: 154-163.
28. Park SS, Stankiewicz P, Bi W, Shaw C, Lehoczky J, et al. (2002) Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. Genome Res 12: 729-738.
29. Shaw CJ, Bi W, Lupski JR (2002) Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2. Am J Hum Genet 71: 1072-1081.
30. Bi W, Park SS, Shaw CJ, Withers MA, Patel PI, et al. (2003) Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2. Am J Hum Genet 73: 1302-1315.
31. Potocki L, Shaw CJ, Stankiewicz P, Lupski JR (2003) Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)]. Genet Med 5: 430-434.
32. Trask BJ, Mefford H, van den Engh G, Massa HF, Juyal RC, et al. (1996) Quantification by flow cytometry of chromosome-17 deletions in Smith-Magenis syndrome patients. Hum Genet 98: 710-718.
33. Stankiewicz P, Shaw CJ, Dapper JD, Wakui K, Shaffer LG, et al. (2003) Genome architecture catalyzes nonrecurrent chromosomal rearrangements. Am J Hum Genet 72: 1101-1116.
34. Shaw CJ, Withers MA, Lupski JR (2004) Uncommon deletions of the Smith-Magenis syndrome region can be recurrent when alternate low-copy repeats act as homologous recombination substrates. Am J Hum Genet 75: 75-81.
35. Liskay RM, Letsou A, Stachelek JL (1987) Homology requirement for efficient gene conversion between duplicated chromosomal sequences in mammalian cells. Genetics 115: 161-167.
36. Waldman AS, Liskay RM (1988) Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology. Mol Cell Biol 8: 5350-5357.
37. Lupski JR (2004) Hotspots of homologous recombination in the human genome: Not all homolgous sequences are equal. Genome Biol 5: 242.
38. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, et al. (1996) A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 12: 288-297.
39. Kauppi L, Jeffreys AJ, Keeney S (2004) Where the crossovers are: Recombination distributions in mammals. Nat Rev Genet 5: 413-424.
40. Crawford DC, Bhangale T, Li N, Hellenthal G, Rieder MJ, et al. (2004) Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat Genet 36: 700-706.
41. McVean GA, Myers SR, Hunt S, Deloukas P, Bentley DR, et al. (2004) The fine-scale structure of recombination rate variation in the human genome. Science 304: 581-584.
42. Smith G (1998) Chi sites and their consequences. In: de Bruijn FJ, Lupski JR, Weinstock GM, editors. Bacterial genomes. New York: Chapman and Hall. pp. 49-66.
43. Bacolla A, Jaworski A, Larson JE, Jakupciak JP, Chuzhanova N, et al. (2004) Breakpoints of gross deletions coincide with non-B DNA conformations. Proc Natl Acad Sei U S A 101: 14162-14167.
44. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J (1993) Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 5: 236-241.
45. Jobling MA, Williams GA, Schiebel GA, Pandya GA, McElreavey GA, et al. (1998) A selective difference between human Y-chromosomal DNA haplotypes. Curr Biol 8: 1391-1394.
46. Osborne LR, Li M, Pober B, Chitayat D, Bodurtha J, et al. (2001) A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet 29: 321-325.
47. Giglio S, Calvari V, Gregato G, Gimelli G, Camanini S, et al. (2002) Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation. Am J Hum Genet 71: 276-285.
48. Gimelli G, Pujana MA, Patricelli MG, Russo S, Giardino D, et al. (2003) Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions. Hum Mol Genet 12: 849-858.
49. Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, et al. (2005) A common inversion under selection in Europeans. Nat Genet 37: 129-137.
50. Barbouti A, Stankiewicz P, Nusbaum C, Cuomo C, Cook A, et al. (2004) The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats. Am J Hum Genet 74: 1-10.
51. Shaw CJ, Lupski JR (2005) Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms. Hum Genet 116: 1-7.
52. Stankiewicz P, Park SS, Holder SE, Waters CS, Palmer RW, et al. (2001) Trisomy 17p10-p12 resulting from a supernumerary marker chromosome derived from chromosome 17: Molecular analysis and delineation of the phenotype. Clin Genet 60: 336-344.
53. Shaw CJ, Stankiewicz P, Bien-Willner G, Bello SC, Shaw CA, et al. (2004) Small marker chromosomes in two patients with segmental aneusomy for proximal 17p. Hum Genet 115: 1-7.
54. Yatsenko SA, Treadwell-Deering D, Krull K, Glaze D, Stankiewicz P, et al. (2005) Trisomy 17p10-p12 due to mosaic supernumery marker chromosome: Delineation of molecular breakpoints and clinical phenotype and comparison to other proximal 17p segmental duplications. Am J Med Genet 138: 175-180.
55. Inoue K, Osaka H, Imaizumi K, Nezu A, Takanashi J, et al. (1999) Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: Molecular mechanism and phenotypic manifestations. Ann Neurol 45: 624-632.
56. Inoue K, Osaka H, Thurston VC, Clarke JTR, Yoneyama A, et al. (2002) Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71: 838-853.
57. Nobile C, Toffolatti L, Rizzi F, Simionati B, Nigro V, et al. (2002) Analysis of 22 deletion breakpoints in dystrophin intron 49. Hum Genet 110: 418-421.
58. Fioretos T, Strömbeck B, Sandberg T, Johansson B, Billström R, et al. (1999) Isochromosome I7q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 94: 225-232.
59. Bien-Willner G, Stankiewicz P, Lupski JR, Northup JK, Velagaleti GVN (2005) Interphase FISH screening for the LCR-mediated common rearrangement of isochromosome 17q in primary myelofirosis. Am J Hematol 79: 309-313.
60. Kleinjan D, van Heynigen V (2005) Long-range control of gene expression: Emerging mechanisms and disruption in disease. Am J Hum Genet 76: 8-32.
61. Velagaleti GVN, Bien-Willner GA, Northup JK, Lockhart LH, Hawkins JC, et al. (2005) Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of S0X9 in two patients with campomelic dysplasia. Am J Hum Genet 76: 652-662.
62. Lee JA, Madrid RE, Sperle K, Ritterson CM, Hobson GM, et al. (2005) Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol. In press.
63. Shaffer LG, Ledbetter DH, Lupski JR (2001) Molecular cytogenetics of contiguous gene syndromes: Mechanisms and consequences. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, et al., editors. The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill. pp. 6077-6096.
64. Kurotaki N, Shen JJ, Touyama M, Kondoh T, Visser R, et al. (2005) Phenotypic consequences of genetic variation at hemizygous alleles: Sotos syndrome is a contiguous gene syndrome incorporating coagulation factor twelve (FXII) deficiency. Genet Med 7: 479-483.
65. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
66. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
67. Carter NP (2004) As normal as normal can be? Nat Genet 36: 931-932.
68. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/ AIDS susceptibility. Science 307: 1434-1440.
69. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, et al. (2005) Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 77: 78-88.
70. Bailey JA, Yavor AM, Massa HF, Trask BJ, Eichler EE (2001) Segmental duplications: Organization and impact within the current human genome project assembly. Genome Res 11: 1005-1017.
71. Bailey JA, Liu G, Eichler EE (2003) An Alu transposition model for the origin and expansion of human segmental duplications. Am J Hum Genet 73: 823-834.
72. Eichler EE (2001) Recent duplication, domain accretion and the dynamic mutation of the human genome. Trends Genet 17: 661-669.
73. Versalovic J, Koeuth T, Britton R, Geszvain K, Lupski JR (1993) Conservation and evolution of the rpsU-dnaG-rpoD macromolecular synthesis operon in bacteria. Mol Microbiol 8: 343-355.
74. Weinstock GM (1994) Bacterial genomes: Mapping and stability. ASM News 60: 73-78.
75. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
76. Carter NP, Vetrie D (2004) Applications of genomic microarrays to explore human chromosome structure and function. Hum Mol Genet 13(Spec No 2): R297-R302.